Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Cell Rep ; 42(8): 112848, 2023 08 29.
Article in English | MEDLINE | ID: mdl-37515770

ABSTRACT

Oligodendrocytes are specialized cells that insulate and support axons with their myelin membrane, allowing proper brain function. Here, we identify lamin A/C (LMNA/C) as essential for transcriptional and functional stability of myelinating oligodendrocytes. We show that LMNA/C levels increase with differentiation of progenitors and that loss of Lmna in differentiated oligodendrocytes profoundly alters their chromatin accessibility and transcriptional signature. Lmna deletion in myelinating glia is compatible with normal developmental myelination. However, altered chromatin accessibility is detected in fully differentiated oligodendrocytes together with increased expression of progenitor genes and decreased levels of lipid-related transcription factors and inner mitochondrial membrane transcripts. These changes are accompanied by altered brain metabolism, lower levels of myelin-related lipids, and altered mitochondrial structure in oligodendrocytes, thereby resulting in myelin thinning and the development of a progressively worsening motor phenotype. Overall, our data identify LMNA/C as essential for maintaining the transcriptional and functional stability of myelinating oligodendrocytes.


Subject(s)
Nuclear Lamina , Transcriptome , Transcriptome/genetics , Cells, Cultured , Oligodendroglia/metabolism , Myelin Sheath/metabolism , Chromatin/metabolism
2.
Front Immunol ; 14: 1190379, 2023.
Article in English | MEDLINE | ID: mdl-37304291

ABSTRACT

Cancer is the leading cause of death worldwide. Cancer immunotherapy involves reinvigorating the patient's own immune system to fight against cancer. While novel approaches like Chimeric Antigen Receptor (CAR) T cells, bispecific T cell engagers, and immune checkpoint inhibitors have shown promising efficacy, Cytokine Release Syndrome (CRS) is a serious adverse effect and remains a major concern. CRS is a phenomenon of immune hyperactivation that results in excessive cytokine secretion, and if left unchecked, it may lead to multi-organ failure and death. Here we review the pathophysiology of CRS, its occurrence and management in the context of cancer immunotherapy, and the screening approaches that can be used to assess CRS and de-risk drug discovery earlier in the clinical setting with more predictive pre-clinical data. Furthermore, the review also sheds light on the potential immunotherapeutic approaches that can be used to overcome CRS associated with T cell activation.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Neoplasms , Humans , Cytokine Release Syndrome/etiology , Cytokine Release Syndrome/therapy , Drug Discovery , Immune Checkpoint Inhibitors , Immunotherapy , Neoplasms/therapy
3.
J Cell Biochem ; 119(7): 5843-5851, 2018 07.
Article in English | MEDLINE | ID: mdl-29575238

ABSTRACT

Mantle cell lymphoma (MCL) presents a therapeutic challenge. The B cell targeting agent, ibrutinib, is currently one of the most effective second-line therapies for MCL, but frequently leads to development of drug resistance, and short overall survival time upon relapse. Olaparib targets tumor cells with deficiencies in single-strand DNA break repair and thus may slow the development of genetic drug resistance. We found that the olaparib-ibrutinib combination significantly inhibits cell culture growth compared to either drug alone in two genetically distinct MCL cell lines. Moreover, these inhibitory effects are either additive or synergistic, depending on genetic background. Culture growth is inhibited due to increases in apoptosis, cell death, and cell cycle arrest, and the magnitude of each is cell line dependent. The additive and synergistic inhibition of this combination additionally supports a therapeutic strategy involving lower dosing of each drug to reduce potential side effects.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Proliferation/drug effects , Drug Synergism , Lymphoma, Mantle-Cell/drug therapy , Phthalazines/pharmacology , Piperazines/pharmacology , Pyrazoles/pharmacology , Pyrimidines/pharmacology , Adenine/analogs & derivatives , Antineoplastic Combined Chemotherapy Protocols , Drug Resistance, Neoplasm , Humans , Lymphoma, Mantle-Cell/pathology , Piperidines , Tumor Cells, Cultured
4.
Cell Rep ; 13(2): 337-49, 2015 Oct 13.
Article in English | MEDLINE | ID: mdl-26411685

ABSTRACT

Expression of Pitx2 on the left side of the embryo patterns left-right (LR) organs including the dorsal mesentery (DM), whose asymmetric cell behavior directs gut looping. Despite the importance of organ laterality, chromatin-level regulation of Pitx2 remains undefined. Here, we show that genes immediately neighboring Pitx2 in chicken and mouse, including a long noncoding RNA (Pitx2 locus-asymmetric regulated RNA or Playrr), are expressed on the right side and repressed by Pitx2. CRISPR/Cas9 genome editing of Playrr, 3D fluorescent in situ hybridization (FISH), and variations of chromatin conformation capture (3C) demonstrate that mutual antagonism between Pitx2 and Playrr is coordinated by asymmetric chromatin interactions dependent on Pitx2 and CTCF. We demonstrate that transcriptional and morphological asymmetries driving gut looping are mirrored by chromatin architectural asymmetries at the Pitx2 locus. We propose a model whereby Pitx2 auto-regulation directs chromatin topology to coordinate LR transcription of this locus essential for LR organogenesis.


Subject(s)
Chromatin/genetics , Gene Expression Regulation, Developmental , Homeodomain Proteins/genetics , Intestinal Mucosa/metabolism , RNA, Long Noncoding/genetics , Repressor Proteins/metabolism , Transcription Factors/genetics , Animals , Base Sequence , CCCTC-Binding Factor , Chick Embryo , Chromatin/chemistry , Genetic Loci , Intestines/embryology , Mice , Molecular Sequence Data , Morphogenesis , Repressor Proteins/genetics , Homeobox Protein PITX2
5.
Invest Ophthalmol Vis Sci ; 56(6): 3776-87, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26066746

ABSTRACT

PURPOSE: The purpose of this study was to identify the molecular basis and characterize the pathological consequences of a spontaneous mutation named cone photoreceptor function loss 8 (cpfl8) in a mouse model with a significantly reduced cone electroretinography (ERG) response. METHODS: The chromosomal position for the recessive cpfl8 mutation was determined by DNA pooling and by subsequent genotyping with simple sequence length polymorphic markers in an F2 intercross phenotyped by ERG. Genes within the candidate region of both mutants and controls were directly sequenced and compared. The effects of the mutation were examined in longitudinal studies by light microscopy, marker analysis, transmission electron microscopy, and ERG. RESULTS: The cpfl8 mutation was mapped to Chromosome 12, and a premature stop codon was identified in the spectrin repeat containing nuclear envelope 2 (Syne2) gene. The reduced cone ERG response was due to a significant reduction in cone photoreceptors. Longitudinal studies of the early postnatal retina indicated that the cone photoreceptors fail to develop properly, rod photoreceptors mislocalize to the inner nuclear layer, and both rods and cones undergo apoptosis prematurely. Moreover, we observed migration defects of secondary neurons and ectopic Müller cell bodies in the outer nuclear layer in early postnatal development. CONCLUSIONS: SYNE2 is important for normal retinal development. We have determined that not only is photoreceptor nuclear migration affected, but also the positions of Müller glia and secondary neurons are disturbed early in retinal development. The cpfl8 mouse model will serve as an important resource for further examining the role of nuclear scaffolding and migration in the developing retina.


Subject(s)
Mutation , Nerve Tissue Proteins/genetics , Neuroglia/pathology , Neurons/pathology , Nuclear Proteins/genetics , Photoreceptor Cells/pathology , Retina/pathology , Animals , Mice , Mice, Inbred C57BL
6.
J Immunol ; 189(5): 2374-82, 2012 Sep 01.
Article in English | MEDLINE | ID: mdl-22826323

ABSTRACT

Activation-induced cytidine deaminase (AID) initiates DNA double-strand breaks (DSBs) in the IgH gene (Igh) to stimulate isotype class switch recombination (CSR), and widespread breaks in non-Igh (off-target) loci throughout the genome. Because the DSBs that initiate class switching occur during the G1 phase of the cell cycle, and are repaired via end joining, CSR is considered a predominantly G1 reaction. By contrast, AID-induced non-Igh DSBs are repaired by homologous recombination. Although little is known about the connection between the cell cycle and either induction or resolution of AID-mediated non-Igh DSBs, their repair by homologous recombination implicates post-G1 phases. Coordination of DNA breakage and repair during the cell cycle is critical to promote normal class switching and prevent genomic instability. To understand how AID-mediated events are regulated through the cell cycle, we have investigated G1-to-S control in AID-dependent genome-wide DSBs. We find that AID-mediated off-target DSBs, like those induced in the Igh locus, are generated during G1. These data suggest that AID-mediated DSBs can evade G1/S checkpoint activation and persist beyond G1, becoming resolved during S phase. Interestingly, DSB resolution during S phase can promote not only non-Igh break repair, but also Ig CSR. Our results reveal novel cell cycle dynamics in response to AID-initiated DSBs, and suggest that the regulation of the repair of these DSBs through the cell cycle may ensure proper class switching while preventing AID-induced genomic instability.


Subject(s)
Cytidine Deaminase/physiology , DNA Breaks, Double-Stranded , Immunoglobulin Class Switching/genetics , Immunoglobulin Isotypes/genetics , S Phase/genetics , S Phase/immunology , Animals , B-Lymphocytes/cytology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Cells, Cultured , Cytidine Deaminase/deficiency , Cytidine Deaminase/genetics , DNA Repair/genetics , DNA Repair/immunology , G1 Phase/genetics , G1 Phase/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout
7.
PLoS One ; 6(3): e18065, 2011 Mar 25.
Article in English | MEDLINE | ID: mdl-21464947

ABSTRACT

BACKGROUND: Lamin A (LMNA) is a component of the nuclear lamina and is mutated in several human diseases, including Emery-Dreifuss muscular dystrophy (EDMD; OMIM ID# 181350) and the premature aging syndrome Hutchinson-Gilford progeria syndrome (HGPS; OMIM ID# 176670). Cells from progeria patients exhibit cell cycle defects in both interphase and mitosis. Mouse models with loss of LMNA function have reduced Retinoblastoma protein (RB1) activity, leading to aberrant cell cycle control in interphase, but how mitosis is affected by LMNA is not well understood. RESULTS: We examined the cell cycle and structural phenotypes of cells from mice with the Lmna allele, Disheveled hair and ears (Lmna(Dhe)). We found that dermal fibroblasts from heterozygous Lmna(Dhe) (Lmna(Dhe/+)) mice exhibit many phenotypes of human laminopathy cells. These include severe perturbations to the nuclear shape and lamina, increased DNA damage, and slow growth rates due to mitotic delay. Interestingly, Lmna(Dhe/+) fibroblasts also had reduced levels of hypophosphorylated RB1 and the non-SMC condensin II-subunit D3 (NCAP-D3), a mitosis specific centromere condensin subunit that depends on RB1 activity. Mitotic check point control by mitotic arrest deficient-like 1 (MAD2L1) also was perturbed in Lmna(Dhe/+) cells. Lmna(Dhe/+) fibroblasts were consistently aneuploid and had higher levels of micronuclei and anaphase bridges than normal fibroblasts, consistent with chromosome segregation defects. CONCLUSIONS: These data indicate that RB1 may be a key regulator of cellular phenotype in laminopathy-related cells, and suggest that the effects of LMNA on RB1 include both interphase and mitotic cell cycle control.


Subject(s)
Aneuploidy , Dermis/pathology , Fibroblasts/metabolism , Fibroblasts/pathology , Lamin Type A/metabolism , Mitosis , Retinoblastoma Protein/metabolism , Animals , Cell Nucleus Size , Chromosome Segregation , Chromosomes, Mammalian/metabolism , DNA/metabolism , DNA Damage , Dermis/metabolism , Humans , Lamin Type B/metabolism , Metaphase , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Micronuclei, Chromosome-Defective , Nuclear Lamina/metabolism , Nuclear Lamina/pathology , Spindle Apparatus/metabolism
8.
Chromosoma ; 120(1): 61-71, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20703494

ABSTRACT

Nuclear localization influences the expression of certain genes. Chromosomal rearrangements can reposition genes in the nucleus and thus could impact the expression of genes far from chromosomal breakpoints. However, the extent to which chromosomal rearrangements influence nuclear organization and gene expression is poorly understood. We examined mouse progenitor B cell lymphomas with a common translocation, der(12)t(12;15), which fuses a gene-rich region of mouse chromosome 12 (Mmu 12) with a gene-poor region of mouse chromosome 15 (Mmu 15). We found that sequences 2.3 Mb proximal and 2.7 Mb distal to the der(12)t(12;15) breakpoint had different nuclear positions measured relative to the nuclear radius. However, their positions were similar on unrearranged chromosomes in the same tumor cells and normal progenitor B cells. In addition, higher-order chromatin folding marked by three-dimensional gene clustering was not significantly altered for the 7 Mb of Mmu 15 sequence distal to this translocation breakpoint. Translocation also did not correspond to significant changes in gene expression in this region. Thus, any changes to Mmu 15 structure and function imposed by the der(12)t(12;15) translocation are constrained to sequences near (<2.5 Mb) the translocation junction. These data contrast with those of certain other chromosomal rearrangements and suggest that significant changes to Mmu 15 sequence are structurally and functionally tolerated in the tumor cells examined.


Subject(s)
Chromatin/metabolism , Chromosomes, Mammalian/metabolism , Gene Expression Regulation, Neoplastic , Lymphoma, B-Cell/metabolism , Translocation, Genetic , Animals , Cell Line, Tumor , Chromatin/genetics , Chromosomes, Mammalian/genetics , Lymphoma, B-Cell/genetics , Mice
9.
PLoS One ; 5(4): e9959, 2010 Apr 01.
Article in English | MEDLINE | ID: mdl-20376364

ABSTRACT

BACKGROUND: Investigations of naturally-occurring mutations in animal models provide important insights and valuable disease models. Lamins A and C, along with lamin B, are type V intermediate filament proteins which constitute the proteinaceous boundary of the nucleus. LMNA mutations in humans cause a wide range of phenotypes, collectively termed laminopathies. To identify the mutation and investigate the phenotype of a spontaneous, semi-dominant mutation that we have named Disheveled hair and ear (Dhe), which causes a sparse coat and small external ears in heterozygotes and lethality in homozygotes by postnatal day 10. FINDINGS: Genetic mapping identified a point mutation in the Lmna gene, causing a single amino acid change, L52R, in the coiled coil rod domain of lamin A and C proteins. Cranial sutures in Dhe/+ mice failed to close. Gene expression for collagen types I and III in sutures was deficient. Skulls were small and disproportionate. Skeletons of Dhe/+ mice were hypomineralized and total body fat was deficient in males. In homozygotes, skin and oral mucosae were dysplastic and ulcerated. Nuclear morphometry of cultured cells revealed gene dose-dependent blebbing and wrinkling. CONCLUSION: Dhe mice should provide a useful new model for investigations of the pathogenesis of laminopathies.


Subject(s)
Adaptor Proteins, Signal Transducing/genetics , Disease Models, Animal , Lamin Type A/genetics , Phosphoproteins/genetics , Point Mutation , Animals , Dishevelled Proteins , Female , Genotype , Humans , Male , Mice , Mice, Knockout , Phenotype
10.
J Cell Sci ; 122(Pt 20): 3729-37, 2009 Oct 15.
Article in English | MEDLINE | ID: mdl-19773359

ABSTRACT

Chromatin adapts a distinct structure and epigenetic state in embryonic stem cells (ESCs), but how chromatin is three-dimensionally organized within the ESC nucleus is poorly understood. Because nuclear location can influence gene expression, we examined the nuclear distributions of chromatin with key epigenetic marks in ESC nuclei. We focused on chromatin at the nuclear periphery, a compartment that represses some but not all associated genes and accumulates facultative heterochromatin in differentiated cells. Using a quantitative, cytological approach, we measured the nuclear distributions of genes in undifferentiated mouse ESCs according to epigenetic state and transcriptional activity. We found that trimethyl histone H3 lysine 27 (H3K27-Me(3)), which marks repressed gene promoters, is enriched at the ESC nuclear periphery. In addition, this compartment contains 10-15% of chromatin with active epigenetic marks and hundreds of transcription sites. Surprisingly, comparisons with differentiated cell types revealed similar nuclear distributions of active chromatin. By contrast, H3K27-Me(3) was less concentrated at the nuclear peripheries of differentiated cells. These findings demonstrate that the nuclear periphery is an epigenetically dynamic compartment that might be distinctly marked in pluripotent ESCs. In addition, our data indicate that the nuclear peripheries of multiple cell types can contain a significant fraction of both active and repressed genes.


Subject(s)
Cell Compartmentation/genetics , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Nuclear Envelope/genetics , Transcription, Genetic , Animals , Chromatin/metabolism , Epigenesis, Genetic , Fibroblasts/cytology , Fibroblasts/metabolism , Gene Expression Regulation, Developmental , Mice , NIH 3T3 Cells , Neurons/cytology , Neurons/metabolism , Organ Specificity/genetics
12.
J Cell Biol ; 174(1): 27-38, 2006 Jul 03.
Article in English | MEDLINE | ID: mdl-16818717

ABSTRACT

Specific mammalian genes functionally and dynamically associate together within the nucleus. Yet, how an array of many genes along the chromosome sequence can be spatially organized and folded together is unknown. We investigated the 3D structure of a well-annotated, highly conserved 4.3-Mb region on mouse chromosome 14 that contains four clusters of genes separated by gene "deserts." In nuclei, this region forms multiple, nonrandom "higher order" structures. These structures are based on the gene distribution pattern in primary sequence and are marked by preferential associations among multiple gene clusters. Associating gene clusters represent expressed chromatin, but their aggregation is not simply dependent on ongoing transcription. In chromosomes with aggregated gene clusters, gene deserts preferentially align with the nuclear periphery, providing evidence for chromosomal region architecture by specific associations with functional nuclear domains. Together, these data suggest dynamic, probabilistic 3D folding states for a contiguous megabase-scale chromosomal region, supporting the diverse activities of multiple genes and their conserved primary sequence organization.


Subject(s)
Chromosome Mapping , Chromosomes, Mammalian/chemistry , Chromosomes, Mammalian/genetics , Genome , Animals , Cell Nucleus/genetics , Cells, Cultured , Chromatin/genetics , Fibroblasts/metabolism , In Situ Hybridization, Fluorescence , Mice , Models, Biological , NIH 3T3 Cells
13.
Mol Biol Cell ; 15(1): 197-206, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14617810

ABSTRACT

Previous studies have shown that in a given cell type, certain active genes associate with SC-35 domains, nuclear regions rich in RNA metabolic factors and excluded from heterochromatin. This organization is not seen for all active genes; therefore, it is important to determine whether and when this locus-specific organization arises during development and differentiation of specific cell types. Here, we investigate whether gene organization relative to SC-35 domains is cell type specific by following several muscle and nonmuscle genes in human fibroblasts, committed but proliferative myoblasts, and terminally differentiated muscle. Although no change was seen for other loci, two muscle genes (Human beta-cardiac myosin heavy chain and myogenin) became localized to the periphery of an SC-35 domain in terminally differentiated muscle nuclei, but not in proliferative myoblasts or in fibroblasts. There was no apparent change in gene localization relative to either the chromosome territory or the heterochromatic compartment; thus, the gene repositioning seemed to occur specifically with respect to SC-35 domains. This gene relocation adjacent to a prominent SC-35 domain was recapitulated in mouse 3T3 cells induced into myogenesis by introduction of MyoD. Results demonstrate a cell type-specific reorganization of specific developmentally regulated loci relative to large domains of RNA metabolic factors, which may facilitate developmental regulation of genome expression.


Subject(s)
Cell Nucleus/metabolism , Muscle Development/physiology , Myoblasts/metabolism , Myogenin/metabolism , Ventricular Myosins/metabolism , Animals , Cell Differentiation/physiology , Cells, Cultured , Chick Embryo , Chromatin/metabolism , Humans , In Situ Hybridization, Fluorescence , Mice , Microscopy, Fluorescence , MyoD Protein/metabolism , NIH 3T3 Cells , Protein Subunits/metabolism
14.
J Cell Biol ; 162(6): 981-90, 2003 Sep 15.
Article in English | MEDLINE | ID: mdl-12975345

ABSTRACT

Typically, eukaryotic nuclei contain 10-30 prominent domains (referred to here as SC-35 domains) that are concentrated in mRNA metabolic factors. Here, we show that multiple specific genes cluster around a common SC-35 domain, which contains multiple mRNAs. Nonsyntenic genes are capable of associating with a common domain, but domain "choice" appears random, even for two coordinately expressed genes. Active genes widely separated on different chromosome arms associate with the same domain frequently, assorting randomly into the 3-4 subregions of the chromosome periphery that contact a domain. Most importantly, visualization of six individual chromosome bands showed that large genomic segments ( approximately 5 Mb) have striking differences in organization relative to domains. Certain bands showed extensive contact, often aligning with or encircling an SC-35 domain, whereas others did not. All three gene-rich reverse bands showed this more than the gene-poor Giemsa dark bands, and morphometric analyses demonstrated statistically significant differences. Similarly, late-replicating DNA generally avoids SC-35 domains. These findings suggest a functional rationale for gene clustering in chromosomal bands, which relates to nuclear clustering of genes with SC-35 domains. Rather than random reservoirs of splicing factors, or factors accumulated on an individual highly active gene, we propose a model of SC-35 domains as functional centers for a multitude of clustered genes, forming local euchromatic "neighborhoods."


Subject(s)
Cell Nucleus/genetics , Chromosome Structures/genetics , Euchromatin/genetics , Multigene Family/genetics , Nuclear Proteins/genetics , Ribonucleoproteins , Cell Line , Chromosome Banding , Collagen Type I/biosynthesis , Collagen Type I/genetics , DNA Replication/genetics , Eukaryotic Cells/cytology , Eukaryotic Cells/metabolism , Fluorescent Antibody Technique , Gene Expression Regulation/genetics , Humans , RNA, Messenger/genetics , Serine-Arginine Splicing Factors
15.
J Struct Biol ; 140(1-3): 131-9, 2002.
Article in English | MEDLINE | ID: mdl-12490161

ABSTRACT

A fundamental question of mRNA metabolism concerns the spatial organization of the steps involved in generating mature transcripts and their relationship to SC-35 domains, nuclear compartments enriched in mRNA metabolic factors and poly A+ RNA. Because poly A+ RNA in SC-35 domains remains after transcription inhibition, a prevailing view has been that most or all SC-35 domains do not contain protein-encoding mRNAs but stable RNAs with nuclear functions and thus that these compartments do not have direct roles in mRNA synthesis or transport. However, the transcription, splicing, and transport of transcripts from a specific gene have been shown to occur in association with two of these 15-30 nuclear compartments. Here we show that virtually all SC-35 domains can contain specific mRNAs and that these persist in SC-35 domains after treatment with three different transcription-inhibitory drugs. This suggests perturbation of an mRNA transport step that normally occurs in SC-35 domains and is post-transcriptional but still dependent on ongoing transcription. Finally, even after several hours of transcription arrest, these transcripts do not disperse from SC-35 domains, indicating that they are structurally constrained within them. Our findings importantly suggest a spatially direct role for all SC-35 domains in the coupled steps of mRNA metabolism and transport.


Subject(s)
RNA, Messenger/metabolism , Cell Line , Cell Nucleus/metabolism , Chromatin/metabolism , Collagen/biosynthesis , Collagen Type I/biosynthesis , Collagen Type I, alpha 1 Chain , DNA, Complementary/metabolism , Humans , In Situ Hybridization, Fluorescence , Microscopy, Fluorescence , Nucleic Acid Hybridization , Protein Structure, Tertiary , Ribonucleoproteins, Small Nuclear/metabolism , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...